v3.22.2.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities    
Net loss $ (88,301) $ (68,174)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 15,844 12,222
Depreciation on property and equipment 90 54
Non-cash lease expense 560 551
Other non-cash items 0 740
Changes in operating assets and liabilities:    
Accounts receivable 8,817 (387)
Prepaid expenses and other current assets (10,126) 4,408
Accounts payable (10,967) 1,810
Accrued expenses (1,357) 7,898
Operating lease liabilities (565) (383)
Net cash used in operating activities (86,005) (41,261)
Cash flows from investing activities    
Purchase of property and equipment (73) (62)
Net cash used in investing activities (73) (62)
Cash flows from financing activities    
Capital contributions 0 129
Proceeds from stock options exercised 21 0
Proceeds from investment by Roivant Sciences Ltd. 0 200,000
Net cash provided by financing activities 21 200,129
Effect of exchange rate changes on cash and cash equivalents (1,987) 0
Net change in cash and cash equivalents (88,044) 158,806
Cash and cash equivalents – beginning of period 493,817 400,146
Cash and cash equivalents – end of period $ 405,773 $ 558,952

Source